Xing K - Search Results

1

AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.

Bian X, Shi D, Xing K, Zhou H, Lu L, Yu D, Wu W. Bian X, et al. Among authors: xing k. Clin Transl Med. 2021 Mar;11(3):e352. doi: 10.1002/ctm2.352. Clin Transl Med. 2021. PMID: 33783988 Free PMC article.

2

miR-296-5p suppresses stem cell potency of hepatocellular carcinoma cells via regulating Brg1/Sall4 axis.

Shi DM, Shi XL, Xing KL, Zhou HX, Lu LL, Wu WZ. Shi DM, et al. Cell Signal. 2020 Aug;72:109650. doi: 10.1016/j.cellsig.2020.109650. Epub 2020 Apr 19. Cell Signal. 2020. PMID: 32320856

3

miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway.

Xing K, Bian X, Shi D, Dong S, Zhou H, Xiao S, Bai J, Wu W. Xing K, et al. J Hepatocell Carcinoma. 2023 Dec 6;10:2173-2185. doi: 10.2147/JHC.S433332. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38084209 Free PMC article.

4

A novel strategy of EGFR‑TKI combined chemotherapy in the treatment of human lung cancer with EGFR‑sensitive mutation.

Zhang L, Qi Y, Xing K, Qian S, Zhang P, Wu X. Zhang L, et al. Among authors: xing k. Oncol Rep. 2018 Aug;40(2):1046-1054. doi: 10.3892/or.2018.6499. Epub 2018 Jun 18. Oncol Rep. 2018. PMID: 29917169

5

A novel point mutation in exon 20 of EGFR showed sensitivity to erlotinib.

Xing K, Zhou X, Zhao X, Sun S, Luo Z, Wang H, Yu H, Wang J, Chang J, Wu X, Hu A. Xing K, et al. Med Oncol. 2014 Jul;31(7):36. doi: 10.1007/s12032-014-0036-2. Epub 2014 Jun 8. Med Oncol. 2014. PMID: 24908064

6

Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy.

Xing K, Gu B, Zhang P, Wu X. Xing K, et al. BMC Immunol. 2015 Jun 26;16:39. doi: 10.1186/s12865-015-0103-2. BMC Immunol. 2015. PMID: 26112261 Free PMC article.

7

Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.

Qi Y, Xing K, Zhang L, Zhao F, Yao M, Hu A, Wu X. Qi Y, et al. Among authors: xing k. J Cancer Res Clin Oncol. 2018 Oct;144(10):1945-1957. doi: 10.1007/s00432-018-2720-7. Epub 2018 Aug 6. J Cancer Res Clin Oncol. 2018. PMID: 30090962

8

Effect of clinicopathologic features on survival of patients with thymic carcinomas and thymic neuroendocrine tumors: A population-based analysis.

Song Q, Zhang LL, Qi Y, Xing KL, Wu XH. Song Q, et al. Curr Probl Cancer. 2019 Oct;43(5):411-420. doi: 10.1016/j.currproblcancer.2019.03.004. Epub 2019 Mar 29. Curr Probl Cancer. 2019. PMID: 30952367

9

A framework integrating multiscale in-silico modeling and experimental data predicts CD33CAR-NK cytotoxicity across target cell types.

Ahmad S, Xing K, Rajakaruna H, Stewart WC, Beckwith KA, Nayak I, Kararoudi MN, Lee DA, Das J. Ahmad S, et al. Among authors: xing k. bioRxiv [Preprint]. 2025 Jan 2:2024.12.31.630941. doi: 10.1101/2024.12.31.630941. bioRxiv. 2025. PMID: 39803543 Free PMC article. Preprint.

10

Differences in motivation for biology learning: A measurement invariance testing and latent mean comparison approach.

Dai T, Xing K, Kaplan A, Cromley JG, Mara KR, Perez T. Dai T, et al. Among authors: xing k. Anat Sci Educ. 2025 Jan 5. doi: 10.1002/ase.2544. Online ahead of print. Anat Sci Educ. 2025. PMID: 39757139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters